Oxidative stress is a key factor in inducing cellular senescence and age-related diseases. When the redox balance within the body is disrupted, sustained oxidative stress can lead to cellular senescence. The accumulation of senescent cells, in turn, triggers a variety of age-related diseases. Peroxiredoxin 6 (Prdx6) is a critical target in the intracellular regulation of redox homeostasis.
Recent Advances:
Prdx6 is a widely expressed antioxidant enzyme and the sole member of the peroxiredoxin family endowed with multiple enzymatic functions, including peroxidase activity along with acidic calcium-independent phospholipase A2 (aiPLA2) and lysophosphatidylcholine acyltransferase (LPCAT) activities. Its fundamental physiological functions involve protecting against oxidative stress and maintaining phospholipid homeostasis. Recent studies have shown that Prdx6 is widely involved in the regulation of cellular senescence and influences the development and progression of various age-related diseases.
Critical Issues:
Cellular senescence and age-related diseases, due to their complex mechanisms, lack effective treatments. Therefore, there is an urgent need to identify new therapeutic targets. This review discusses the biological characteristics of Prdx6 and its pathophysiological roles in cellular senescence and age-related diseases. Prdx6 may serve as a potential target for modulating cellular senescence and age-related diseases.
Future Directions:
The regulatory mechanisms of Prdx6 in age-related diseases warrant further investigation. Additionally, conducting drug screening to identify more molecules that can specifically target Prdx6 will provide new strategies for the treatment of age-related diseases. Antioxid. Redox Signal. 43, 400–426.
Get full access to this article
View all access options for this article.
References
1.
Abu-RustumNR, YasharCM, ArendR, et al.NCCN guidelines® insights: Cervical cancer, version 1.2024. J Natl Compr Canc Netw, 2023; 21(12):1224–1233; doi: 10.6004/jnccn.2023.0062
2.
AlqahtaniT, DeoreSL, KideAA, et al.Mitochondrial dysfunction and oxidative stress in Alzheimer’s disease, and Parkinson’s disease, Huntington’s disease and amyotrophic lateral sclerosis -An updated review. Mitochondrion, 2023; 71:83–92; doi: 10.1016/j.mito.2023.05.007
3.
AraújoB, Caridade-SilvaR, Soares-GuedesC, et al.Neuroinflammation and Parkinson’s disease-from neurodegeneration to therapeutic opportunities. Cells, 2022; 11(18); doi: 10.3390/cells11182908
4.
ArevaloJA, Vázquez-MedinaJP. The role of peroxiredoxin 6 in cell signaling. Antioxidants (Basel), 2018; 7(12); doi: 10.3390/antiox7120172
5.
ArrigaR, PacificiF, CapuaniB, et al.Peroxiredoxin 6 is a key antioxidant enzyme in modulating the link between glycemic and lipogenic metabolism. Oxid Med Cell Longev, 2019; 2019:9685607; doi: 10.1155/2019/9685607
6.
AsabaCN, EkabeCJ, AyukHS, et al.Interplay of TLR4 and SARS-CoV-2: Unveiling the complex mechanisms of inflammation and severity in COVID-19 infections. J Inflamm Res, 2024; 17:5077–5091; doi: 10.2147/jir.S474707
7.
AsuniAA, GuridiM, SanchezS, et al.Antioxidant peroxiredoxin 6 protein rescues toxicity due to oxidative stress and cellular hypoxia in vitro, and attenuates prion-related pathology in vivo. Neurochem Int, 2015; 90:152–165; doi: 10.1016/j.neuint.2015.08.006
8.
BhattiJS, BhattiGK, ReddyPH. Mitochondrial dysfunction and oxidative stress in metabolic disorders - A step towards mitochondria based therapeutic strategies. Biochim Biophys Acta Mol Basis Dis, 2017; 1863(5):1066–1077; doi: 10.1016/j.bbadis.2016.11.010
9.
BidookiSH, Sánchez-MarcoJ, Martínez-BeamonteR, et al.Endoplasmic reticulum protein TXNDC5 interacts with PRDX6 and HSPA9 to regulate glutathione metabolism and lipid peroxidation in the hepatic AML12 cell line. Int J Mol Sci, 2023; 24(24); doi: 10.3390/ijms242417131
10.
BillimoriaR, BhattP. Senescence in cancer: Advances in detection and treatment modalities. Biochem Pharmacol, 2023; 215:115739; doi: 10.1016/j.bcp.2023.115739
11.
BlesaJ, PrzedborskiS. Parkinson’s disease: Animal models and dopaminergic cell vulnerability. Front Neuroanat, 2014; 8:155; doi: 10.3389/fnana.2014.00155
12.
BoccardiV, MaranoL. Aging, cancer, and inflammation: The telomerase connection. Int J Mol Sci, 2024; 25(15); doi: 10.3390/ijms25158542
13.
BolducJ, KoruzaK, LuoT, et al.Peroxiredoxins wear many hats: Factors that fashion their peroxide sensing personalities. Redox Biol, 2021; 42:101959; doi: 10.1016/j.redox.2021.101959
14.
BrinkmannC, BrixiusK. Peroxiredoxins and sports: New insights on the antioxidative defense. J Physiol Sci, 2013; 63(1):1–5; doi: 10.1007/s12576-012-0237-4
15.
CaoH, LiZ, JinT, et al.Maslinic acid supplementation prevents di(2-ethylhexyl) phthalate-induced apoptosis via PRDX6 in peritubular myoid cells of Chinese forest musk deer. J Environ Sci (China), 2024; 143:47–59; doi: 10.1016/j.jes.2023.07.034
16.
CarreteroA, Gomez-CabreraMC, Rios-NavarroC, et al.Early reductive stress and late onset overexpression of antioxidant enzymes in experimental myocardial infarction. Free Radic Res, 2020; 54(2–3):173–184; doi: 10.1080/10715762.2020.1735632
17.
ChangXZ, LiDQ, HouYF, et al.Identification of the functional role of peroxiredoxin 6 in the progression of breast cancer. Breast Cancer Res, 2007; 9(6):R76; doi: 10.1186/bcr1789
18.
ChatterjeeN, WalkerGC. Mechanisms of DNA damage, repair, and mutagenesis. Environ Mol Mutagen, 2017; 58(5):235–263; doi: 10.1002/em.22087
19.
ChenJW, DodiaC, FeinsteinSI, et al.1-Cys peroxiredoxin, a bifunctional enzyme with glutathione peroxidase and phospholipase A2 activities. J Biol Chem, 2000; 275(37):28421–28427; doi: 10.1074/jbc.M005073200
20.
ChenZ, InagueA, KaushalK, et al.PRDX6 contributes to selenocysteine metabolism and ferroptosis resistance. Mol Cell, 2024; 84(23):4645–4659.e4649; doi: 10.1016/j.molcel.2024.10.027
21.
ChenX, TzekovR, SuM, et al.Hydrogen peroxide-induced oxidative damage and protective role of peroxiredoxin 6 protein via EGFR/ERK signaling pathway in RPE cells. Front Aging Neurosci, 2023; 15:1169211; doi: 10.3389/fnagi.2023.1169211
22.
ChengC, LiuK, ShenF, et al.Astragaloside IV targets PRDX6, inhibits the activation of RAC subunit in NADPH oxidase 2 for oxidative damage. Phytomedicine, 2023; 114:154795; doi: 10.1016/j.phymed.2023.154795
23.
ChhunchhaB, FatmaN, KuboE, et al.Curcumin abates hypoxia-induced oxidative stress based-ER stress-mediated cell death in mouse hippocampal cells (HT22) by controlling Prdx6 and NF-κB regulation. Am J Physiol Cell Physiol, 2013; 304(7):C636–C655; doi: 10.1152/ajpcell.00345.2012
24.
ChhunchhaB, KuboE, SinghDP. Clock protein Bmal1 and Nrf2 cooperatively control aging or oxidative response and redox homeostasis by regulating rhythmic expression of Prdx6. Cells, 2020; 9(8); doi: 10.3390/cells9081861
25.
ChhunchhaB, KuboE, SinghDP. Switching of redox signaling by Prdx6 expression decides cellular fate by hormetic phenomena involving Nrf2 and reactive oxygen species. Cells, 2022; 11(8); doi: 10.3390/cells11081266
26.
ChhunchhaB, KumarR, KuboE, et al.Prdx6 regulates Nlrp3 inflammasome activation-driven inflammatory response in lens epithelial cells. Int J Mol Sci, 2023; 24(22); doi: 10.3390/ijms242216276
27.
ChhunchhaB, SinghP, SinghDP, et al.Ginkgolic acid rescues lens epithelial cells from injury caused by redox regulated-aberrant sumoylation signaling by reviving Prdx6 and Sp1 expression and activities. Int J Mol Sci, 2018; 19(11); doi: 10.3390/ijms19113520
28.
ChhunchhaB, SinghP, StamerWD, et al.Prdx6 retards senescence and restores trabecular meshwork cell health by regulating reactive oxygen species. Cell Death Discov, 2017; 3:17060; doi: 10.1038/cddiscovery.2017.60
29.
ChowhanRK, HotumalaniS, RahamanH, et al.pH induced conformational alteration in human peroxiredoxin 6 might be responsible for its resistance against lysosomal pH or high temperature. Sci Rep, 2021; 11(1):9657; doi: 10.1038/s41598-021-89093-8
30.
ChowhanRK, RahamanH, SinghLR. Structural basis of peroxidase catalytic cycle of human Prdx6. Sci Rep, 2020; 10(1):17416; doi: 10.1038/s41598-020-74052-6
31.
DavereyA, AgrawalSK. Curcumin alleviates oxidative stress and mitochondrial dysfunction in astrocytes. Neuroscience, 2016; 333:92–103; doi: 10.1016/j.neuroscience.2016.07.012
32.
DavereyA, AgrawalSK. Regulation of Prdx6 by Nrf2 mediated through aiPLA2 in white matter reperfusion injury. Mol Neurobiol, 2021; 58(3):1275–1289; doi: 10.1007/s12035-020-02182-z
33.
DavisonEJ, PenningtonK, HungCC, et al.Proteomic analysis of increased Parkin expression and its interactants provides evidence for a role in modulation of mitochondrial function. Proteomics, 2009; 9(18):4284–4297; doi: 10.1002/pmic.200900126
34.
Di MiccoR, KrizhanovskyV, BakerD, et al.Cellular senescence in ageing: From mechanisms to therapeutic opportunities. Nat Rev Mol Cell Biol, 2021; 22(2):75–95; doi: 10.1038/s41580-020-00314-w
35.
DongW, LiuJ, ZhangY, et al.DNA damages in hepatocytes are amended by an inflammation-driven rescue repair mechanism in chronic hepatitis B. Pathol Res Pract, 2024; 260:155391; doi: 10.1016/j.prp.2024.155391
36.
DuggerBN, DicksonDW. Pathology of neurodegenerative diseases. Cold Spring Harb Perspect Biol, 2017; 9(7); doi: 10.1101/cshperspect.a028035
37.
El EterE, Al MasriA, HabibS, et al.Novel links among peroxiredoxins, endothelial dysfunction, and severity of atherosclerosis in type 2 diabetic patients with peripheral atherosclerotic disease. Cell Stress Chaperones, 2014; 19(2):173–181; doi: 10.1007/s12192-013-0442-y
38.
ElwakeelA. Abrogating the interaction between p53 and mortalin (Grp75/HSPA9/mtHsp70) for cancer therapy: The story so far. Front Cell Dev Biol, 2022; 10:879632; doi: 10.3389/fcell.2022.879632
FinkelT, HolbrookNJ. Oxidants, oxidative stress and the biology of ageing. Nature, 2000; 408(6809):239–247; doi: 10.1038/35041687
44.
FisherAB. Peroxiredoxin 6 in the repair of peroxidized cell membranes and cell signaling. Arch Biochem Biophys, 2017; 617:68–83; doi: 10.1016/j.abb.2016.12.003
45.
FisherAB. Peroxiredoxin 6: A bifunctional enzyme with glutathione peroxidase and phospholipase A2 activities. Antioxid Redox Signal, 2011; 15(3):831–844; doi: 10.1089/ars.2010.3412
46.
FisherAB. The phospholipase A(2) activity of peroxiredoxin 6. J Lipid Res, 2018; 59(7):1132–1147; doi: 10.1194/jlr.R082578
47.
FisherAB, DodiaC, ManevichY, et al.Phospholipid hydroperoxides are substrates for non-selenium glutathione peroxidase. J Biol Chem, 1999; 274(30):21326–21334; doi: 10.1074/jbc.274.30.21326
48.
FisherAB, DodiaC, SorokinaEM, et al.A novel lysophosphatidylcholine acyl transferase activity is expressed by peroxiredoxin 6. J Lipid Res, 2016; 57(4):587–596; doi: 10.1194/jlr.M064758
FrickC, RumgayH, VignatJ, et al.Quantitative estimates of preventable and treatable deaths from 36 cancers worldwide: A population-based study. Lancet Glob Health, 2023; 11(11):e1700–e1712; doi: 10.1016/s2214-109x(23)00406-0
51.
FujiiT, FujiiJ, TaniguchiN. Augmented expression of peroxiredoxin VI in rat lung and kidney after birth implies an antioxidative role. Eur J Biochem, 2001; 268(2):218–225; doi: 10.1046/j.1432-1033.2001.01843.x
52.
FujitaH, TanakaYK, OgataS, et al.PRDX6 augments selenium utilization to limit iron toxicity and ferroptosis. Nat Struct Mol Biol, 2024; 31(8):1277–1285; doi: 10.1038/s41594-024-01329-z
53.
GaoL, MengJ, YueC, et al.Integrative analysis the characterization of peroxiredoxins in pan-cancer. Cancer Cell Int, 2021; 21(1):366; doi: 10.1186/s12935-021-02064-x
54.
GarnettS, de BruynsA, Provencher-TomV, et al.Metabolic regulator IAPP (Amylin) is required for BRAF and RAS oncogene-induced senescence. Mol Cancer Res, 2021; 19(5):874–885; doi: 10.1158/1541-7786.Mcr-20-0879
55.
Godoy-LugoJA, ThorwaldMA, HuiDY, et al.Chronic angiotensin receptor activation promotes hepatic triacylglycerol accumulation during an acute glucose challenge in obese-insulin-resistant OLETF rats. Endocrine, 2022; 75(1):92–107; doi: 10.1007/s12020-021-02834-7
56.
GoemaereJ, KnoopsB. Peroxiredoxin distribution in the mouse brain with emphasis on neuronal populations affected in neurodegenerative disorders. J Comp Neurol, 2012; 520(2):258–280; doi: 10.1002/cne.22689
57.
GoncalvesK, SullivanK, PhelanS. Differential expression and function of peroxiredoxin 1 and peroxiredoxin 6 in cancerous MCF-7 and noncancerous MCF-10A breast epithelial cells. Cancer Invest, 2012; 30(1):38–47; doi: 10.3109/07357907.2011.629382
58.
González-RojoS, Fernández-DíezC, LombóM, et al.Distribution of DNA damage in the human sperm nucleus: Implications of the architecture of the sperm head. Asian J Androl, 2020; 22(4):401–408; doi: 10.4103/aja.aja_26_19
59.
GuanC, ZahidS, MinhasAS, et al.Polycystic ovary syndrome: A “risk-enhancing” factor for cardiovascular disease. Fertil Steril, 2022; 117(5):924–935; doi: 10.1016/j.fertnstert.2022.03.009
60.
GülowK, TümenD, HeumannP, et al.Unraveling the role of reactive oxygen species in T lymphocyte signaling. Int J Mol Sci, 2024; 25(11); doi: 10.3390/ijms25116114
61.
HalimM, HalimA. The effects of inflammation, aging and oxidative stress on the pathogenesis of diabetes mellitus (type 2 diabetes). Diabetes Metab Syndr, 2019; 13(2):1165–1172; doi: 10.1016/j.dsx.2019.01.040
62.
HarbeckN, GnantM. Breast cancer. Lancet, 2017; 389(10074):1134–1150; doi: 10.1016/s0140-6736(16)31891-8
63.
HasanovaN, KuboE, KumamotoY, et al.Age-related cataracts and Prdx6: Correlation between severity of lens opacity, age and the level of Prdx 6 expression. Br J Ophthalmol, 2009; 93(8):1081–1084; doi: 10.1136/bjo.2008.152272
64.
HayflickL, MoorheadPS. The serial cultivation of human diploid cell strains. Exp Cell Res, 1961; 25:585–621; doi: 10.1016/0014-4827(61)90192-6
65.
HeJ, QinM, ChenY, et al.Epigenetic regulation of matrix metalloproteinases in inflammatory diseases: A narrative review. Cell Biosci, 2020; 10:86; doi: 10.1186/s13578-020-00451-x
66.
HeY, XuW, XiaoY, et al.Overexpression of Peroxiredoxin 6 (PRDX6) promotes the aggressive phenotypes of esophageal squamous cell carcinoma. J Cancer, 2018; 9(21):3939–3949; doi: 10.7150/jca.26041
67.
HeL, ZhangY, FangY, et al.Classical swine fever virus induces oxidative stress in swine umbilical vein endothelial cells. BMC Vet Res, 2014; 10:279; doi: 10.1186/s12917-014-0279-3
68.
HuX, LuE, PanC, et al.Overexpression and biological function of PRDX6 in human cervical cancer. J Cancer, 2020; 11(9):2390–2400; doi: 10.7150/jca.39892
69.
HuangWS, HuangCY, HsiehMC, et al.Expression of PRDX6 correlates with migration and invasiveness of colorectal cancer cells. Cell Physiol Biochem, 2018; 51(6):2616–2630; doi: 10.1159/000495934
70.
HuangCF, SunZJ, ZhaoYF, et al.Increased expression of peroxiredoxin 6 and cyclophilin A in squamous cell carcinoma of the tongue. Oral Dis, 2011; 17(3):328–334; doi: 10.1111/j.1601-0825.2010.01730.x
71.
HughesNP, XuL, NielsenCH, et al.A blood biomarker for monitoring response to anti-EGFR therapy. Cancer Biomark, 2018; 22(2):333–344; doi: 10.3233/cbm-171149
ItoJ, NakamuraT, ToyamaT, et al.PRDX6 dictates ferroptosis sensitivity by directing cellular selenium utilization. Mol Cell, 2024; 84(23):4629–4644.e4629; doi: 10.1016/j.molcel.2024.10.028
74.
JemalA, CenterMM, DeSantisC, et al.Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev, 2010; 19(8):1893–1907; doi: 10.1158/1055-9965.Epi-10-0437
75.
JeongJ, KimY, Kyung SeongJ, et al.Comprehensive identification of novel post-translational modifications in cellular peroxiredoxin 6. Proteomics, 2012; 12(9):1452–1462; doi: 10.1002/pmic.201100558
76.
JiaW, DongC, LiB. Anti-Oxidant and pro-oxidant effects of peroxiredoxin 6: A potential target in respiratory diseases. Cells, 2023; 12(1); doi: 10.3390/cells12010181
77.
JiangC, JiangW. Integrated bioinformatics and machine learning strategies reveal PRDX6 as the key ferroptosis-associated molecular biosignature of heart failure. Gen Physiol Biophys, 2022; 41(5):365–380; doi: 10.4149/gpb_2022029
78.
JinXIN, FuWAN, ZhouJ, et al.Oxymatrine attenuates oxidized low-density lipoprotein-induced HUVEC injury by inhibiting NLRP3 inflammasome-mediated pyroptosis via the activation of the SIRT1/Nrf2 signaling pathway. Int J Mol Med, 2021; 48(4); doi: 10.3892/ijmm.2021.5020
79.
JinK, ShiY, ZhangH, et al.A TNFα/Miz1-positive feedback loop inhibits mitophagy in hepatocytes and propagates non-alcoholic steatohepatitis. J Hepatol, 2023; 79(2):403–416; doi: 10.1016/j.jhep.2023.03.039
80.
KangSW, BainesIC, RheeSG. Characterization of a mammalian peroxiredoxin that contains one conserved cysteine. J Biol Chem, 1998; 273(11):6303–6311; doi: 10.1074/jbc.273.11.6303
81.
KimHJ, KimH, LeeJH, et al.Toll-like receptor 4 (TLR4): New insight immune and aging. Immun Ageing, 2023a;20(1):67; doi: 10.1186/s12979-023-00383-3
82.
KimJE, LeeDS, KangTC. Sp1-Mediated Prdx6 upregulation leads to clasmatodendrosis by increasing its aiPLA2 activity in the CA1 astrocytes in chronic epilepsy rats. Antioxidants (Basel), 2022; 11(10); doi: 10.3390/antiox11101883
83.
KimSS, ShinH, AhnKG, et al.Quantifiable peptide library bridges the gap for proteomics based biomarker discovery and validation on breast cancer. Sci Rep, 2023b;13(1):8991; doi: 10.1038/s41598-023-36159-4
84.
KrishnaiahSY, DodiaC, SorokinaEM, et al.Binding sites for interaction of peroxiredoxin 6 with surfactant protein A. Biochim Biophys Acta, 2016; 1864(4):419–425; doi: 10.1016/j.bbapap.2015.12.009
85.
KuboE, ChhunchhaB, SinghP, et al.Sulforaphane reactivates cellular antioxidant defense by inducing Nrf2/ARE/Prdx6 activity during aging and oxidative stress. Sci Rep, 2017; 7(1):14130; doi: 10.1038/s41598-017-14520-8
86.
KudlovaN, De SanctisJB, HajduchM. Cellular senescence: Molecular targets, biomarkers, and senolytic drugs. Int J Mol Sci, 2022; 23(8); doi: 10.3390/ijms23084168
87.
KumariA, ChowhanRK, KakchingtabamP, et al.Peroxiredoxin-6: A guardian of lung pathophysiologies. Curr Protein Pept Sci, 2021; 22(9):666–674; doi: 10.2174/1389203722666211109101853
88.
KüminA, SchäferM, EppN, et al.Peroxiredoxin 6 is required for blood vessel integrity in wounded skin. J Cell Biol, 2007; 179(4):747–760; doi: 10.1083/jcb.200706090
89.
LagalDJ, Montes-OsunaAM, Ortiz-OlivenciaA, et al.Tumoral malignancy decreases coupled with higher ROS and lipid peroxidation in HCT116 colon cancer cells upon loss of PRDX6. Antioxidants (Basel), 2024a;13(7); doi: 10.3390/antiox13070881
90.
LagalDJ, Ortiz-AlcántaraÁ, PedrajasJR, et al.Loss of peroxiredoxin 6 alters lipid composition and distribution resulting in increased sensitivity to ferroptosis. Biochem J, 2024b;481(24):1997–2015; doi: 10.1042/bcj20240445
91.
LanaJV, RiosA, TakeyamaR, et al.Nebulized glutathione as a key antioxidant for the treatment of oxidative stress in neurodegenerative conditions. Nutrients, 2024; 16(15); doi: 10.3390/nu16152476
92.
LawrenceM, GoyalA, PathakS, et al.Cellular senescence and inflammaging in the bone: Pathways, genetics, anti-aging strategies and interventions. Int J Mol Sci, 2024; 25(13); doi: 10.3390/ijms25137411
93.
LeeKM, GiltnaneJM, BalkoJM, et al.MYC and MCL1 cooperatively promote chemotherapy-resistant breast cancer stem cells via regulation of mitochondrial oxidative phosphorylation. Cell Metab, 2017; 26(4):633–647.e637; doi: 10.1016/j.cmet.2017.09.009
94.
LeeSB, HoJN, YoonSH, et al.Peroxiredoxin 6 promotes lung cancer cell invasion by inducing urokinase-type plasminogen activator via p38 kinase, phosphoinositide 3-kinase, and Akt. Mol Cells, 2009; 28(6):583–588; doi: 10.1007/s10059-009-0152-6
95.
LeeS, JiaB, LiuJ, et al.A 1-Cys peroxiredoxin from a thermophilic archaeon moonlights as a molecular chaperone to protect protein and DNA against stress-induced damage. PLoS One, 2015b;10(5):e0125325; doi: 10.1371/journal.pone.0125325
96.
LeeJH, JungM, HongJ, et al.Loss of RNA-binding protein HuR facilitates cellular senescence through posttranscriptional regulation of TIN2 mRNA. Nucleic Acids Res, 2018; 46(8):4271–4285; doi: 10.1093/nar/gky223
97.
LeeDH, JungYY, ParkMH, et al.Peroxiredoxin 6 confers protection against nonalcoholic fatty liver disease through maintaining mitochondrial function. Antioxid Redox Signal, 2019; 31(5):387–402; doi: 10.1089/ars.2018.7544
98.
LeeEY, KangJY, KimKW. Expression of cyclooxygenase-2, peroxiredoxin I, peroxiredoxin 6 and nuclear factor-κB in oral squamous cell carcinoma. Oncol Lett, 2015a;10(5):3129–3136; doi: 10.3892/ol.2015.3705
99.
LiK, DengZ, LeiC, et al.The role of oxidative stress in tumorigenesis and progression. Cells, 2024; 13(5); doi: 10.3390/cells13050441
100.
LiX, LiC, ZhangW, et al.Inflammation and aging: Signaling pathways and intervention therapies. Signal Transduct Target Ther, 2023; 8(1):239; doi: 10.1038/s41392-023-01502-8
101.
LiY, WangF, ImaniS, et al.Natural killer cells: Friend or foe in metabolic diseases? Front Immunol, 2021b;12:614429; doi: 10.3389/fimmu.2021.614429
102.
LiZ, XiaoJ, LiuM, et al.Notch3 regulates ferroptosis via ROS-induced lipid peroxidation in NSCLC cells. FEBS Open Bio, 2022; 12(6):1197–1205; doi: 10.1002/2211-5463.13393
103.
LiH, ZhangD, LiB, et al.PRDX6 overexpression promotes proliferation, invasion, and migration of A549 cells in vitro and in vivo. Cancer Manag Res, 2021a;13:1245–1255; doi: 10.2147/cmar.S284195
LiaoJ, ZhangY, ChenX, et al.The roles of peroxiredoxin 6 in brain diseases. Mol Neurobiol, 2021; 58(9):4348–4364; doi: 10.1007/s12035-021-02427-5
106.
LinY, JiangM, ChenW, et al.Cancer and ER stress: Mutual crosstalk between autophagy, oxidative stress and inflammatory response. Biomed Pharmacother, 2019; 118:109249; doi: 10.1016/j.biopha.2019.109249
107.
LiuRM. Aging, cellular senescence, and Alzheimer’s disease. Int J Mol Sci, 2022; 23(4); doi: 10.3390/ijms23041989
108.
LiuX, ZhangJ, LiJ, et al.Pharmacological inhibition of ALCAT1 mitigates amyotrophic lateral sclerosis by attenuating SOD1 protein aggregation. Mol Metab, 2022; 63:101536; doi: 10.1016/j.molmet.2022.101536
109.
Lo CocoD, LopezG, CorraoS. Cognitive impairment and stroke in elderly patients. Vasc Health Risk Manag, 2016; 12:105–116; doi: 10.2147/vhrm.S75306
110.
LomnytskaMI, BeckerS, GemollT, et al.Impact of genomic stability on protein expression in endometrioid endometrial cancer. Br J Cancer, 2012; 106(7):1297–1305; doi: 10.1038/bjc.2012.67
111.
López-GruesoMJ, LagalDJ, García-JiménezÁF, et al.Knockout of PRDX6 induces mitochondrial dysfunction and cell cycle arrest at G2/M in HepG2 hepatocarcinoma cells. Redox Biol, 2020; 37:101737; doi: 10.1016/j.redox.2020.101737
112.
LuHF, ZhouYC, HuTY, et al.Unraveling the role of NLRP3 inflammasome in allergic inflammation: Implications for novel therapies. Front Immunol, 2024; 15:1435892; doi: 10.3389/fimmu.2024.1435892
113.
LuoJ, WangX, WeiT, et al.Peroxinredoxin 6 reduction accelerates cigarette smoke extract-induced senescence by regulating autophagy in BEAS-2B cells. Exp Ther Med, 2023; 26(2):375; doi: 10.3892/etm.2023.12074
114.
MaS, ZhangX, ZhengL, et al.Peroxiredoxin 6 Is a crucial factor in the initial step of mitochondrial clearance and is upstream of the PINK1-Parkin pathway. Antioxid Redox Signal, 2016; 24(9):486–501; doi: 10.1089/ars.2015.6336
115.
ManevichY, FeinsteinSI, FisherAB. Activation of the antioxidant enzyme 1-CYS peroxiredoxin requires glutathionylation mediated by heterodimerization with pi GST. Proc Natl Acad Sci USA, 2004; 101(11):3780–3785; doi: 10.1073/pnas.0400181101
116.
ManevichY, FisherAB. Peroxiredoxin 6, a 1-Cys peroxiredoxin, functions in antioxidant defense and lung phospholipid metabolism. Free Radic Biol Med, 2005; 38(11):1422–1432; doi: 10.1016/j.freeradbiomed.2005.02.011
117.
ManevichY, ReddyKS, ShuvaevaT, et al.Structure and phospholipase function of peroxiredoxin 6: Identification of the catalytic triad and its role in phospholipid substrate binding. J Lipid Res, 2007; 48(10):2306–2318; doi: 10.1194/jlr.M700299-JLR200
118.
ManevichY, ShuvaevaT, DodiaC, et al.Binding of peroxiredoxin 6 to substrate determines differential phospholipid hydroperoxide peroxidase and phospholipase A(2) activities. Arch Biochem Biophys, 2009; 485(2):139–149; doi: 10.1016/j.abb.2009.02.008
119.
Martínez-CuéC, RuedaN. Cellular senescence in neurodegenerative diseases. Front Cell Neurosci, 2020; 14:16; doi: 10.3389/fncel.2020.00016
120.
MarurS, ForastiereAA. Head and neck squamous cell carcinoma: Update on epidemiology, diagnosis, and treatment. Mayo Clin Proc, 2016; 91(3):386–396; doi: 10.1016/j.mayocp.2015.12.017
121.
MattsonMP, ArumugamTV. Hallmarks of brain aging: Adaptive and pathological modification by metabolic states. Cell Metab, 2018; 27(6):1176–1199; doi: 10.1016/j.cmet.2018.05.011
122.
MercurioL, BaileyJ, GlickAB, et al.RAS-activated PI3K/AKT signaling sustains cellular senescence via P53/P21 axis in experimental models of psoriasis. J Dermatol Sci, 2024; 115(1):21–32; doi: 10.1016/j.jdermsci.2024.03.002
123.
MinY, KimMJ, LeeS, et al.Inhibition of TRAF6 ubiquitin-ligase activity by PRDX1 leads to inhibition of NFKB activation and autophagy activation. Autophagy, 2018; 14(8):1347–1358; doi: 10.1080/15548627.2018.1474995
124.
MinY, WiSM, ShinD, et al.Peroxiredoxin-6 negatively regulates bactericidal activity and NF-κB activity by interrupting TRAF6-ECSIT complex. Front Cell Infect Microbiol, 2017; 7:94; doi: 10.3389/fcimb.2017.00094
125.
MognatoM, Burdak-RothkammS, RothkammK. Interplay between DNA replication stress, chromatin dynamics and DNA-damage response for the maintenance of genome stability. Mutat Res Rev Mutat Res, 2021; 787:108346; doi: 10.1016/j.mrrev.2020.108346
126.
MoloneyJN, CotterTG. ROS signalling in the biology of cancer. Semin Cell Dev Biol, 2018; 80:50–64; doi: 10.1016/j.semcdb.2017.05.023
127.
Moradi VasteganiS, NasrolahiA, GhaderiS, et al.Mitochondrial dysfunction and Parkinson’s disease: Pathogenesis and therapeutic strategies. Neurochem Res, 2023; 48(8):2285–2308; doi: 10.1007/s11064-023-03904-0
128.
MorrisEJ, JhaS, RestainoCR, et al.Discovery of a novel ERK inhibitor with activity in models of acquired resistance to BRAF and MEK inhibitors. Cancer Discov, 2013; 3(7):742–750; doi: 10.1158/2159-8290.Cd-13-0070
129.
MuR, ChangM, FengC, et al.Analysis of the expression of PRDX6 in patients with hepatocellular carcinoma and its effect on the phenotype of hepatocellular carcinoma cells. Curr Genomics, 2024; 25(1):2–11; doi: 10.2174/0113892029273682240111052317
130.
Muñoz-EspínD, SerranoM. Cellular senescence: From physiology to pathology. Nat Rev Mol Cell Biol, 2014; 15(7):482–496; doi: 10.1038/nrm3823
131.
NakamuraT, OshimaM, YasudaM, et al.Alteration of molecular assembly of peroxiredoxins from hyperthermophilic archaea. J Biochem, 2017; 162(6):415–422; doi: 10.1093/jb/mvx045
132.
NickoloffJA, JaiswalAS, SharmaN, et al.Cellular responses to widespread DNA replication stress. Int J Mol Sci, 2023; 24(23); doi: 10.3390/ijms242316903
133.
NicolussiA, D’InzeoS, MincioneG, et al.PRDX1 and PRDX6 are repressed in papillary thyroid carcinomas via BRAF V600E-dependent and -independent mechanisms. Int J Oncol, 2014; 44(2):548–556; doi: 10.3892/ijo.2013.2208
134.
PacificiF, ArrigaR, SoriceGP, et al.Peroxiredoxin 6, a novel player in the pathogenesis of diabetes. Diabetes, 2014; 63(10):3210–3220; doi: 10.2337/db14-0144
135.
PacificiF, Della MorteD, CapuaniB, et al.Peroxiredoxin6, a multitask antioxidant enzyme involved in the pathophysiology of chronic noncommunicable diseases. Antioxid Redox Signal, 2019; 30(3):399–414; doi: 10.1089/ars.2017.7427
136.
PacificiF, Della-MorteD, CapuaniB, et al.Peroxiredoxin 6 modulates insulin secretion and beta cell death via a mitochondrial dynamic network. Front Endocrinol (Lausanne), 2022; 13:842575; doi: 10.3389/fendo.2022.842575
137.
PacificiF, Della-MorteD, PiermariniF, et al.Prdx6 plays a main role in the crosstalk between aging and metabolic sarcopenia. Antioxidants (Basel), 2020; 9(4); doi: 10.3390/antiox9040329
138.
Pagaza-StraffonC, MarchatLA, HerreraL, et al.Evaluation of a panel of tumor-associated antigens in breast cancer. Cancer Biomark, 2020; 27(2):207–211; doi: 10.3233/cbm-190708
139.
PaneniF, Diaz CañestroC, LibbyP, et al.The aging cardiovascular system: Understanding it at the cellular and clinical levels. J Am Coll Cardiol, 2017; 69(15):1952–1967; doi: 10.1016/j.jacc.2017.01.064
140.
PankiewiczJE, DiazJR, Martá-ArizaM, et al.Peroxiredoxin 6 mediates protective function of astrocytes in Aβ proteostasis. Mol Neurodegener, 2020; 15(1):50; doi: 10.1186/s13024-020-00401-8
141.
ParfenyukSB, GlushkovaOV, SharapovMG, et al.Protective effects of peroxiredoxin 6 in pro-inflammatory response model using raw 264.7 macrophages. Biochemistry (Mosc), 2023; 88(8):1156–1164; doi: 10.1134/s0006297923080096
142.
ParkJY, LeeJY, KimY, et al.Latilactobacillus sakei Wikim0066 protects skin through MMP regulation on UVB-Irradiated in vitro and in vivo model. Nutrients, 2023; 15(3); doi: 10.3390/nu15030726
PengL, JiY, LiY, et al.PRDX6-iPLA2 aggravates neuroinflammation after ischemic stroke via regulating astrocytes-induced M1 microglia. Cell Commun Signal, 2024; 22(1):76; doi: 10.1186/s12964-024-01476-2
145.
Pérez-TorresI, Castrejón-TéllezV, SotoME, et al.Oxidative stress, plant natural antioxidants, and obesity. Int J Mol Sci, 2021; 22(4); doi: 10.3390/ijms22041786
146.
PhasukS, PairojanaT, SureshP, et al.Enhanced contextual fear memory in peroxiredoxin 6 knockout mice is associated with hyperactivation of MAPK signaling pathway. Mol Brain, 2021; 14(1):42; doi: 10.1186/s13041-021-00754-1
147.
PiccaA, GuerraF, CalvaniR, et al.Mitochondrial dysfunction, protein misfolding and neuroinflammation in parkinson’s disease: Roads to biomarker discovery. Biomolecules, 2021; 11(10); doi: 10.3390/biom11101508
PirsonM, KnoopsB. Expression of peroxiredoxins and thioredoxins in the mouse spinal cord during embryonic development. J Comp Neurol, 2015; 523(17):2599–2617; doi: 10.1002/cne.23807
150.
PowerJH, AsadS, ChatawayTK, et al.Peroxiredoxin 6 in human brain: Molecular forms, cellular distribution and association with Alzheimer’s disease pathology. Acta Neuropathol, 2008; 115(6):611–622; doi: 10.1007/s00401-008-0373-3
151.
PowerJH, ShannonJM, BlumbergsPC, et al.Nonselenium glutathione peroxidase in human brain: Elevated levels in Parkinson’s disease and dementia with lewy bodies. Am J Pathol, 2002; 161(3):885–894; doi: 10.1016/s0002-9440(10)64249-6
152.
RahamanH, HerojitK, SinghLR, et al.Structural and functional diversity of the peroxiredoxin 6 enzyme family. Antioxid Redox Signal, 2024; 40(13–15):759–775; doi: 10.1089/ars.2023.0287
153.
RalatLA, ManevichY, FisherAB, et al.Direct evidence for the formation of a complex between 1-cysteine peroxiredoxin and glutathione S-transferase pi with activity changes in both enzymes. Biochemistry, 2006; 45(2):360–372; doi: 10.1021/bi0520737
154.
RheeSG, KilIS. Multiple functions and regulation of mammalian peroxiredoxins. Annu Rev Biochem, 2017; 86:749–775; doi: 10.1146/annurev-biochem-060815-014431
155.
RheeSG, WooHA, KangD. The role of peroxiredoxins in the transduction of H(2)O(2) signals. Antioxid Redox Signal, 2018; 28(7):537–557; doi: 10.1089/ars.2017.7167
156.
RodierF, CampisiJ. Four faces of cellular senescence. J Cell Biol, 2011; 192(4):547–556; doi: 10.1083/jcb.201009094
157.
RolfsF, HuberM, GruberF, et al.Dual role of the antioxidant enzyme peroxiredoxin 6 in skin carcinogenesis. Cancer Res, 2013; 73(11):3460–3469; doi: 10.1158/0008-5472.Can-12-4369
158.
SadeghiN, BoissonneaultG, TavalaeeM, et al.Oxidative versus reductive stress: A delicate balance for sperm integrity. Syst Biol Reprod Med, 2023; 69(1):20–31; doi: 10.1080/19396368.2022.2119181
159.
SalovskaB, KondelovaA, PimkovaK, et al.Peroxiredoxin 6 protects irradiated cells from oxidative stress and shapes their senescence-associated cytokine landscape. Redox Biol, 2022; 49:102212; doi: 10.1016/j.redox.2021.102212
160.
SantosM, MeloT, MaurícioT, et al.The non-enzymatic oxidation of phosphatidylethanolamine and phosphatidylserine and their intriguing roles in inflammation dynamics and diseases. FEBS Lett, 2024; 598(17):2174–2189; doi: 10.1002/1873-3468.14992
161.
SchattauerSS, BediniA, SummersF, et al.Reactive Oxygen Species (ROS) generation is stimulated by κ opioid receptor activation through phosphorylated c-Jun N-terminal kinase and inhibited by p38 mitogen-activated protein kinase (MAPK) activation. J Biol Chem, 2019; 294(45):16884–16896; doi: 10.1074/jbc.RA119.009592
162.
ScheltensP, De StrooperB, KivipeltoM, et al.Alzheimer’s disease. Lancet, 2021; 397(10284):1577–1590; doi: 10.1016/s0140-6736(20)32205-4
163.
SerhanCN, SulcinerML. Resolution medicine in cancer, infection, pain and inflammation: Are we on track to address the next Pandemic? Cancer Metastasis Rev, 2023; 42(1):13–17; doi: 10.1007/s10555-023-10091-5
164.
ShahnajS, ChowhanRK, MeeteiPA, et al.Hyperoxidation of peroxiredoxin 6 induces alteration from dimeric to oligomeric state. Antioxidants (Basel), 2019; 8(2); doi: 10.3390/antiox8020033
165.
ShanshanY, BeibeiJ, LiT, et al.Phospholipase A2 of peroxiredoxin 6 plays a critical role in cerebral ischemia/reperfusion inflammatory injury. Front Cell Neurosci, 2017; 11:99; doi: 10.3389/fncel.2017.00099
166.
SharapovMG, GlushkovaOV, ParfenyukSB, et al.The role of TLR4/NF-κB signaling in the radioprotective effects of exogenous Prdx6. Arch Biochem Biophys, 2021; 702:108830; doi: 10.1016/j.abb.2021.108830
167.
SharapovMG, GoncharovRG, ParfenyukSB, et al.Effect of peroxiredoxin 6 on p53 transcription factor level. Biochemistry (Mosc), 2022a;87(8):839–849; doi: 10.1134/s0006297922080156
168.
SharapovMG, GoncharovRG, ParfenyukSB, et al.The role of phospholipase activity of peroxiredoxin 6 in its transmembrane transport and protective properties. Int J Mol Sci, 2022b;23(23); doi: 10.3390/ijms232315265
169.
SharapovMG, NovoselovVI, GudkovSV. Radioprotective role of peroxiredoxin 6. Antioxidants (Basel), 2019; 8(1); doi: 10.3390/antiox8010015
170.
ShenW, YangL, YangY, et al.PRDX6 promotes fatty acid oxidation via PLA2-Dependent PPARα activation in rats fed high-fat diet. Antioxid Redox Signal, 2023; 38(16–18):1184–1200; doi: 10.1089/ars.2022.0065
171.
ShiH, LiuX, WangY, et al.Activation of the JAK1/STAT1 signaling pathway is associated with peroxiredoxin 6 expression levels in human epididymis epithelial cells. Folia Histochem Cytobiol, 2022; 60(3):226–236; doi: 10.5603/FHC.a2022.0021
172.
ShibataS, ShibataN, ShibataT, et al.The role of Prdx6 in the protection of cells of the crystalline lens from oxidative stress induced by UV exposure. Jpn J Ophthalmol, 2016; 60(5):408–418; doi: 10.1007/s10384-016-0461-1
173.
SidyakinAA, KayshevaAL, KopylovAT, et al.Proteomic analysis of cerebral cortex extracts from sus scrofa with induced hemorrhagic stroke. J Mol Neurosci, 2018; 65(1):28–34; doi: 10.1007/s12031-018-1064-8
174.
SiegelRL, MillerKD, JemalA. Cancer statistics, 2020. CA Cancer J Clin, 2020; 70(1):7–30; doi: 10.3322/caac.21590
175.
SinghSP, ChhunchhaB, FatmaN, et al.Delivery of a protein transduction domain-mediated Prdx6 protein ameliorates oxidative stress-induced injury in human and mouse neuronal cells. Am J Physiol Cell Physiol, 2016; 310(1):C1–C16; doi: 10.1152/ajpcell.00229.2015
176.
SinghK, SethiP, DattaS, et al.Advances in gene therapy approaches targeting neuro-inflammation in neurodegenerative diseases. Ageing Res Rev, 2024; 98:102321; doi: 10.1016/j.arr.2024.102321
177.
SongY, BiZ, LiuY, et al.Targeting RAS-RAF-MEK-ERK signaling pathway in human cancer: Current status in clinical trials. Genes Dis, 2023; 10(1):76–88; doi: 10.1016/j.gendis.2022.05.006
178.
Soriano-ArroquiaA, GostageJ, XiaQ, et al.miR-24 and its target gene Prdx6 regulate viability and senescence of myogenic progenitors during aging. Aging Cell, 2021; 20(10):e13475; doi: 10.1111/acel.13475
179.
SorokinaEM, FeinsteinSI, ZhouS, et al.Intracellular targeting of peroxiredoxin 6 to lysosomal organelles requires MAPK activity and binding to 14-3-3ε. Am J Physiol Cell Physiol, 2011; 300(6):C1430–C1441; doi: 10.1152/ajpcell.00285.2010
180.
SoyluH, KaracorK. The effects of hydroxytyrosol on Prdx6 and insulin expression in diabetic rat pancreases. Histochem Cell Biol, 2023; 160(2):127–134; doi: 10.1007/s00418-023-02207-3
SunX, SeidmanJS, ZhaoP, et al.Neutralization of oxidized phospholipids ameliorates non-alcoholic steatohepatitis. Cell Metab, 2020; 31(1):189–206.e188; doi: 10.1016/j.cmet.2019.10.014
183.
TanYQ, ChenHW, LiJ. Astragaloside IV: An effective drug for the treatment of cardiovascular diseases. Drug Des Devel Ther, 2020; 14:3731–3746; doi: 10.2147/dddt.S272355
184.
TangB, NiW, ZhouJ, et al.Peroxiredoxin 6 secreted by Schwann-like cells protects neuron against ischemic stroke in rats via PTEN/PI3K/AKT pathway. Tissue Cell, 2021; 73:101635; doi: 10.1016/j.tice.2021.101635
185.
TaoX, WangD, LiangY, et al.PRDX6 inhibits hepatic stellate cells activation and fibrosis via promoting MANF secretion. Biomed Pharmacother, 2022; 156:113931; doi: 10.1016/j.biopha.2022.113931
186.
TavaresMO, MilanTM, Bighetti-TrevisanRL, et al.Pharmacological inhibition of HDAC6 overcomes cisplatin chemoresistance by targeting cancer stem cells in oral squamous cell carcinoma. J Oral Pathol Med, 2022; 51(6):529–537; doi: 10.1111/jop.13326
187.
TeleanuDM, NiculescuAG, LunguII, et al.An overview of oxidative stress, neuroinflammation, and neurodegenerative diseases. Int J Mol Sci, 2022; 23(11); doi: 10.3390/ijms23115938
188.
TeraoR, AhmedT, SuzumuraA, et al.Oxidative stress-induced cellular senescence in aging retina and age-related macular degeneration. Antioxidants (Basel), 2022; 11(11); doi: 10.3390/antiox11112189
189.
Torres-VelardeJM, AllenKN, Salvador-PascualA, et al.Peroxiredoxin 6 suppresses ferroptosis in lung endothelial cells. Free Radic Biol Med, 2024; 218:82–93; doi: 10.1016/j.freeradbiomed.2024.04.208
190.
TristBG, HareDJ, DoubleKL. Oxidative stress in the aging substantia nigra and the etiology of Parkinson’s disease. Aging Cell, 2019; 18(6):e13031; doi: 10.1111/acel.13031
191.
van der PolA, van GilstWH, VoorsAA, et al.Treating oxidative stress in heart failure: Past, present and future. Eur J Heart Fail, 2019; 21(4):425–435; doi: 10.1002/ejhf.1320
192.
WagnerKH, Cameron-SmithD, WessnerB, et al.Biomarkers of aging: From function to molecular biology. Nutrients, 2016; 8(6); doi: 10.3390/nu8060338
193.
WahligS, LovattM, MehtaJS. Functional role of peroxiredoxin 6 in the eye. Free Radic Biol Med, 2018; 126:210–220; doi: 10.1016/j.freeradbiomed.2018.08.017
194.
WildS, RoglicG, GreenA, et al.Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care, 2004; 27(5):1047–1053; doi: 10.2337/diacare.27.5.1047
195.
WooHA, JeongW, ChangTS, et al.Reduction of cysteine sulfinic acid by sulfiredoxin is specific to 2-cys peroxiredoxins. J Biol Chem, 2005; 280(5):3125–3128; doi: 10.1074/jbc.C400496200
196.
XiaC, ZhouM, DongX, et al.Ginkgo biloba extract inhibits hippocampal neuronal injury caused by mitochondrial oxidative stress in a rat model of Alzheimer’s disease. PLoS One, 2024; 19(8):e0307735; doi: 10.1371/journal.pone.0307735
197.
XiaoCL, LaiHT, ZhouJJ, et al.Nrf2 signaling pathway: Focus on oxidative stress in spinal cord injury. Mol Neurobiol, 2025; 62(2):2230–2249; doi: 10.1007/s12035-024-04394-z
198.
XiongJ, ZhouR, DengX. PRDX6 alleviated heart failure by inhibiting doxorubicin-induced ferroptosis through the JAK2/STAT1 pathway inactivation. In Vitro Cell Dev Biol Anim, 2024; 60(4):354–364; doi: 10.1007/s11626-024-00889-0
199.
XuJ, SuQ, GaoM, et al.Differential expression and effects of peroxiredoxin-6 on drug resistance and cancer stem cell-like properties in non-small cell lung cancer. Onco Targets Ther, 2019; 12:10477–10486; doi: 10.2147/ott.S211125
200.
Yamamuro-TanabeA, MukaiY, KojimaW, et al.An increase in peroxiredoxin 6 expression induces neurotoxic a1 astrocytes in the lumbar spinal cord of amyotrophic lateral sclerosis mice model. Neurochem Res, 2023; 48(12):3571–3584; doi: 10.1007/s11064-023-04003-w
201.
YangD, JinM, BaiC, et al.Peroxiredoxin 6 suppresses Muc5ac overproduction in LPS-induced airway inflammation through H(2)O(2)-EGFR-MAPK signaling pathway. Respir Physiol Neurobiol, 2017; 236:84–90; doi: 10.1016/j.resp.2016.11.012
202.
YangH, LiG, QiuG. Bioinformatics analysis using ATAC-seq and RNA-seq for the identification of 15 gene signatures associated with the prediction of prognosis in hepatocellular carcinoma. Front Oncol, 2021; 11:726551; doi: 10.3389/fonc.2021.726551
203.
YangWY, MengX, WangYR, et al.PRDX6 alleviates lipopolysaccharide-induced inflammation and ferroptosis in periodontitis. Acta Odontol Scand, 2022; 80(7):535–546; doi: 10.1080/00016357.2022.2047780
204.
YaoP, IonaA, KartsonakiC, et al.; China Kadoorie Biobank Collaborative Group. Conventional and genetic associations of adiposity with 1463 proteins in relatively lean Chinese adults. Eur J Epidemiol, 2023; 38(10):1089–1103; doi: 10.1007/s10654-023-01038-9
205.
YapJ, IreiJ, Lozano-GeronaJ, et al.Macrophages in cardiac remodelling after myocardial infarction. Nat Rev Cardiol, 2023; 20(6):373–385; doi: 10.1038/s41569-022-00823-5
206.
Yavarpour-BaliH, Ghasemi-KasmanM, PirzadehM. Curcumin-loaded nanoparticles: A novel therapeutic strategy in treatment of central nervous system disorders. Int J Nanomedicine, 2019; 14:4449–4460; doi: 10.2147/ijn.S208332
207.
YeoIJ, ParkMH, SonDJ, et al.PRDX6 inhibits neurogenesis through downregulation of WDFY1-Mediated TLR4 signal. Mol Neurobiol, 2019; 56(5):3132–3144; doi: 10.1007/s12035-018-1287-2
208.
YinK, ZhangY, ZhangS, et al.Using weighted gene co-expression network analysis to identify key modules and hub genes in tongue squamous cell carcinoma. Medicine (Baltimore), 2019; 98(37):e17100; doi: 10.1097/md.0000000000017100
209.
YuH, YuY, ZhaoZ, et al.Prdx6 is required to protect human corneal epithelial cells against ultraviolet B injury. Eur J Ophthalmol, 2021; 31(2):367–378; doi: 10.1177/1120672119896426
210.
YunHM, ChoiDY, OhKW, et al.PRDX6 exacerbates dopaminergic neurodegeneration in a MPTP mouse model of Parkinson’s disease. Mol Neurobiol, 2015; 52(1):422–431; doi: 10.1007/s12035-014-8885-4
211.
YunHM, JinP, HanJY, et al.Acceleration of the development of Alzheimer’s disease in amyloid beta-infused peroxiredoxin 6 overexpression transgenic mice. Mol Neurobiol, 2013; 48(3):941–951; doi: 10.1007/s12035-013-8479-6
212.
YunHM, ParkKR, LeeHP, et al.PRDX6 promotes lung tumor progression via its GPx and iPLA2 activities. Free Radic Biol Med, 2014; 69:367–376; doi: 10.1016/j.freeradbiomed.2014.02.001
213.
ZhaX, WuG, ZhaoX, et al.PRDX6 protects ARPE-19 cells from oxidative damage via PI3K/AKT signaling. Cell Physiol Biochem, 2015; 36(6):2217–2228; doi: 10.1159/000430186
214.
ZhangW, AmbatiS, Della-FeraMA, et al.Leptin modulated changes in adipose tissue protein expression in ob/ob mice. Obesity (Silver Spring), 2011; 19(2):255–261; doi: 10.1038/oby.2010.166
215.
ZhangQ, HuY, HuJE, et al.Sp1-mediated upregulation of Prdx6 expression prevents podocyte injury in diabetic nephropathy via mitigation of oxidative stress and ferroptosis. Life Sci, 2021; 278:119529; doi: 10.1016/j.lfs.2021.119529
216.
ZhangJ, LinY, DaiX, et al.Metformin treatment improves the spatial memory of aged mice in an APOE genotype-dependent manner. Faseb J, 2019; 33(6):7748–7757; doi: 10.1096/fj.201802718R
217.
ZhangS, WangW, GuQ, et al.Protein and miRNA profiling of radiation-induced skin injury in rats: The protective role of peroxiredoxin-6 against ionizing radiation. Free Radic Biol Med, 2014; 69:96–107; doi: 10.1016/j.freeradbiomed.2014.01.019
218.
ZhangD, WenQ, ZhangR, et al.From cell to gene: Deciphering the mechanism of heart failure with single-cell sequencing. Adv Sci (Weinh), 2024; 11(39):e2308900; doi: 10.1002/advs.202308900
219.
ZhangJ, YanJ. Protective effect of ginkgolic acid in attenuating LDL induced inflammation human peripheral blood mononuclear cells via altering the NF-κB signaling pathway. Front Pharmacol, 2019; 10:1241; doi: 10.3389/fphar.2019.01241
220.
ZhangJK, ZhangZ, GuoZA, et al.The BMSC-derived exosomal lncRNA Mir9-3hg suppresses cardiomyocyte ferroptosis in ischemia-reperfusion mice via the Pum2/PRDX6 axis. Nutr Metab Cardiovasc Dis, 2022; 32(2):515–527; doi: 10.1016/j.numecd.2021.10.017
221.
ZhangXW, ZhuXX, TangDS, et al.Targeting autophagy in Alzheimer’s disease: Animal models and mechanisms. Zool Res, 2023; 44(6):1132–1145; doi: 10.2427/2/j.issn.2095-8137.2023.294
222.
ZhouS, SorokinaEM, HarperS, et al.Peroxiredoxin 6 homodimerization and heterodimerization with glutathione S-transferase pi are required for its peroxidase but not phospholipase A2 activity. Free Radic Biol Med, 2016; 94:145–156; doi: 10.1016/j.freeradbiomed.2016.02.012
223.
ZhuH, BlakeS, KusumaFK, et al.Oncogene-induced senescence: From biology to therapy. Mech Ageing Dev, 2020; 187:111229; doi: 10.1016/j.mad.2020.111229
224.
ZhuangD, MannavaS, GrachtchoukV, et al.C-MYC overexpression is required for continuous suppression of oncogene-induced senescence in melanoma cells. Oncogene, 2008; 27(52):6623–6634; doi: 10.1038/onc.2008.258
